Pod Save America Hosts Call on Democrats to Cut All Israel Military Aid, No Longer Accept AIPAC Funding
Jews, Israelis Targeted in Austria Amid Surge in Antisemitic Incidents; Local Jewish Community Calls for Action
‘All of Our Strength’: Over 1,000 Pro-Israel Activists Gather in DC for Solidarity Conference
‘Devastated’: Wesley LePatner, Killed in Manhattan Mass Shooting, Was a Jewish Communal, Philanthropic Leader
Sen. Angus King Vows to No Longer Vote for Israel Military Aid Until Gaza Conditions Improve
Europe Won’t Pressure Israel to ‘Commit Suicide’ Amid Gaza Backlash, Palestinian State Push, Says Israeli FM
Israel’s National Soccer Coach Attacked in Athens Before Soccer Fans Chant ‘F–K Israel, Free Palestine’ at Match
New York Judge Sentences Neo-Nazi to 5 Years for Livestreaming Bomb Threats Against Jewish Hospitals
US Pressures Lebanon to Issue Cabinet Decision to Disarm Hezbollah Before Talks Continue
UK Plans to Recognize Palestinian State in September Unless Israel Meets Conditions, Starmer Says
Mobile Urinalysis Startup Healthy.io Raises $60 Million
Error: Contact form not found.
by Lilach Baumer / CTech
The homepage of the Healthy.io website. Photo: Screenshot.
JNS.org – Tel Aviv-based mobile health startup Healthy.io Ltd. announced on Thursday the closing of a $60 million series C round led by Corner Ventures, with participation from Samsung’s innovation center Samsung NEXT, Aleph Venture Capital, and Ansonia Holdings. The round brings the company’s total funding to date to $93 million. This is the second funding round Healthy.io held in 2019.
Healthy.io offers a home kit for urine testing capable of analyzing several different parameters, including a range of infections, chronic illnesses, and pregnancy-related complications through a mobile app. Patients use their smartphone camera to scan the dipstick provided in the kit and Healthy.io’s app uses computer vision and artificial intelligence algorithms to analyze chemical color changes to the dipstick and provide users with instant results.
The company also announced it has received a second US Food and Drugs Administration (FDA) clearance for its smartphone-based test, this time as an aid for diagnosing chronic kidney disease.
The company will use the funding to expand its clinical tests and market reach, according to a statement by founder and CEO Yonatan Adiri.
